The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer
Authors
Keywords
Lung cancer, Lung inflammation, <sup>1</sup>H-NMR, Metabolic phenotype, Glutamate, ROC
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-03
DOI
10.1186/s12885-018-4755-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma
- (2016) Evelyne Louis et al. Journal of Thoracic Oncology
- The role of new PET tracers for lung cancer
- (2016) Teresa A. Szyszko et al. LUNG CANCER
- Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
- (2016) Leonor Puchades-Carrasco et al. Oncotarget
- Lung Cancer Screening
- (2015) Lynn T. Tanoue et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A tutorial review: Metabolomics and partial least squares-discriminant analysis – a marriage of convenience or a shotgun wedding
- (2015) Piotr S. Gromski et al. ANALYTICA CHIMICA ACTA
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phenotyping human blood plasma by 1H-NMR: a robust protocol based on metabolite spiking and its evaluation in breast cancer
- (2014) Evelyne Louis et al. Metabolomics
- Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health
- (2014) Lorena Pochini et al. Frontiers in Chemistry
- Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis
- (2013) Iola F Duarte et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- 1H-NMR based metabonomic profiling of human esophageal cancer tissue
- (2013) Liang Wang et al. Molecular Cancer
- Lung Cancer Screening
- (2013) Robert Suh et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- 3.5D dynamic PET image reconstruction incorporating kinetics-based clusters
- (2012) Lijun Lu et al. PHYSICS IN MEDICINE AND BIOLOGY
- Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
- (2011) Cláudia M. Rocha et al. JOURNAL OF PROTEOME RESEARCH
- Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies
- (2011) Ewa Szymańska et al. Metabolomics
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Glutathione in Cancer Cell Death
- (2011) Angel L. Ortega et al. Cancers
- Enhancing metabolomic data analysis with Progressive Consensus Alignment of NMR Spectra (PCANS)
- (2010) Jennifer M Staab et al. BMC BIOINFORMATICS
- Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
- (2010) Joana Carrola et al. JOURNAL OF PROTEOME RESEARCH
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Management of Lung Nodules Detected by Volume CT Scanning
- (2009) Rob J. van Klaveren et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started